Accelerate to the Clinic Novel, New Generation Cell Therapies that are Safer, More Effective and Have Meaningful Impact in Diseases Beyond Oncology
As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
That’s why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your definitive platform focused on the 2.0, next generation innovations in cell therapies.
Join innovators from large pharma, biotech, academia and regulatory boards to hear insights into:
Novel In-Vivo Delivery | Innovations in Gene, Base & Prime Editing | Novel Discovery Platforms | Overcoming the Hostile Tumour Microenvironment | Improving Persistence and Durability for Greater Clinical Outcomes | And More!
Whether you are developing novel constructs, new clinical trial strategies or innovative manufacturing approaches for large scale production, this multi-tracked meeting can support your whole team and provide the tools needed to advance your own pipeline towards clinical and commercial success.
View the event guide now for more details!
Health & Safety Update
Joining From Outside the UK?
Those arriving in the UK no longer need to isolate until receipt of a negative PCR test.
The health, safety and well-being of our community remains our highest priority, therefore, a lateral flow test must be performed within 24 hours of the conference starting and you may be asked to provide proof of a negative result before entering.
Full H&S details can be found in your event guide here.
2022 Speakers Include:
What's New for 2022:
A renewed focus on the latest and greatest novel discovery platforms and clinical updates, with insights into innovations in manufacturing technologies and supply chain strategies
Accelerating Non-T Cell Approaches Focus Day: Explore how to harness the potential of macrophages, NK cells and iPSCs to develop the holy grail of cell therapies
Discover CAR-T Applications beyond Oncology and the blockbuster potential that cell therapies hold in autoimmunity, infectious disease and degenerative disorders
9 New Preconference Workshops: Deep dive into innovative designs for engineering T-Cells, advancing clinical translation of allogeneic products, enhancing patient quality of care using novel combination approaches and more!
Reunite with the CAR-TCR Community!
Don't miss this opportunity to join your industry peers in-person once again for the first time in 2 years.
There's 8+ hours of dedicated networking built into the programme for you to meet 300+ experts from 180+ companies, including new and emerging players in this space.
Here's a taster of who's in the room so far: